Publicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de Burgos (17)

2024

  1. Cómo estimar la composición corporal en la enfermedad de Huntington. Estudio transversal y observacional con bioimpedancia de múltiples frecuencias

    Revista de neurologia, Vol. 78, Núm. 1, pp. 17-25

  2. The association between lifestyle factors and mortality in Huntington's disease

    Neurologia

2023

  1. Association Between Insulin-Like Growth Factor-1 and Social Cognition in Huntington's Disease

    Movement Disorders Clinical Practice, Vol. 10, Núm. 2, pp. 279-284

  2. Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives

    Journal of Personalized Medicine, Vol. 13, Núm. 4

  3. Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers

    Journal of Personalized Medicine, Vol. 13, Núm. 3

  4. Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus

    Pharmacogenomics, Vol. 24, Núm. 12, pp. 651-663

  5. Occupational performance in Huntington’s disease: A cross-sectional study

    British Journal of Occupational Therapy, Vol. 86, Núm. 6, pp. 432-440

  6. Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives

    Journal of Personalized Medicine, Vol. 13, Núm. 3

2022

  1. Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington’s disease

    Neurological Sciences, Vol. 43, Núm. 10, pp. 6079-6085

  2. Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives

    Pharmaceutics, Vol. 14, Núm. 3

  3. Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience

    Cancers, Vol. 14, Núm. 7

2021

  1. Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin

    Frontiers in Pharmacology, Vol. 12

  2. Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers

    Biomedicine and Pharmacotherapy, Vol. 133

  3. Use of azacitidine or decitabine for the up‐front setting in acute myeloid leukaemia: A systematic review and meta‐analysis

    Cancers, Vol. 13, Núm. 22

2020

  1. Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran

    Advances in Therapy, Vol. 37, Núm. 8, pp. 3537-3550

  2. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial

    Trials

  3. Risk of COVID-19 in oncohematological patients

    American journal of blood research, Vol. 10, Núm. 3, pp. 52-53